These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 15048072

  • 1. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
    Huerta-Yepez S, Vega M, Jazirehi A, Garban H, Hongo F, Cheng G, Bonavida B.
    Oncogene; 2004 Jun 24; 23(29):4993-5003. PubMed ID: 15048072
    [Abstract] [Full Text] [Related]

  • 2. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
    Ng CP, Zisman A, Bonavida B.
    Prostate; 2002 Dec 01; 53(4):286-99. PubMed ID: 12430140
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
    Walczak H, Bouchon A, Stahl H, Krammer PH.
    Cancer Res; 2000 Jun 01; 60(11):3051-7. PubMed ID: 10850456
    [Abstract] [Full Text] [Related]

  • 4. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X, Kandasamy K, Srivastava RK.
    Cancer Res; 2003 Mar 01; 63(5):1059-66. PubMed ID: 12615723
    [Abstract] [Full Text] [Related]

  • 5. NFkappaB-mediated upregulation of bcl-xl restrains TRAIL-mediated apoptosis in murine viral hepatitis.
    Zender L, Hütker S, Mundt B, Waltemathe M, Klein C, Trautwein C, Malek NP, Manns MP, Kühnel F, Kubicka S.
    Hepatology; 2005 Feb 01; 41(2):280-8. PubMed ID: 15660391
    [Abstract] [Full Text] [Related]

  • 6. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R, Bedi A.
    Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014
    [Abstract] [Full Text] [Related]

  • 7. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines.
    Guseva NV, Taghiyev AF, Sturm MT, Rokhlin OW, Cohen MB.
    Mol Cancer Res; 2004 Oct 01; 2(10):574-84. PubMed ID: 15498932
    [Abstract] [Full Text] [Related]

  • 8. Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis.
    Sanlioglu AD, Koksal IT, Karacay B, Baykara M, Luleci G, Sanlioglu S.
    Cancer Gene Ther; 2006 Jan 01; 13(1):21-31. PubMed ID: 16052230
    [Abstract] [Full Text] [Related]

  • 9. Apoptotic responsiveness of PC-3 prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand: evidence for differential effects of Bcl-xL and Bcl-2 down-regulation.
    Sonnemann J, Gekeler V, Sagrauske A, Müller C, Hofmann HP, Beck JF.
    Int J Oncol; 2004 Oct 01; 25(4):1171-81. PubMed ID: 15375570
    [Abstract] [Full Text] [Related]

  • 10. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP.
    Kang J, Bu J, Hao Y, Chen F.
    Prostate Cancer Prostatic Dis; 2005 Oct 01; 8(3):274-9. PubMed ID: 15897917
    [Abstract] [Full Text] [Related]

  • 11. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.
    Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW, Wong YC.
    Oncogene; 2003 Jul 17; 22(29):4498-508. PubMed ID: 12881706
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
    Zhang L, Fang B.
    Cancer Gene Ther; 2005 Mar 17; 12(3):228-37. PubMed ID: 15550937
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells.
    Yu R, Mandlekar S, Ruben S, Ni J, Kong AN.
    Cancer Res; 2000 May 01; 60(9):2384-9. PubMed ID: 10811114
    [Abstract] [Full Text] [Related]

  • 14. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
    Bai J, Sui J, Demirjian A, Vollmer CM, Marasco W, Callery MP.
    Cancer Res; 2005 Mar 15; 65(6):2344-52. PubMed ID: 15781649
    [Abstract] [Full Text] [Related]

  • 15. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
    Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki K, Nakata K, Ishii N, Eguchi K.
    Oncogene; 2003 Mar 20; 22(11):1653-62. PubMed ID: 12642868
    [Abstract] [Full Text] [Related]

  • 16. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
    Shankar S, Singh TR, Srivastava RK.
    Prostate; 2004 Sep 15; 61(1):35-49. PubMed ID: 15287092
    [Abstract] [Full Text] [Related]

  • 17. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, Chiao PJ.
    Oncogene; 2002 Sep 19; 21(42):6510-9. PubMed ID: 12226754
    [Abstract] [Full Text] [Related]

  • 18. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
    Jazirehi AR, Huerta-Yepez S, Cheng G, Bonavida B.
    Cancer Res; 2005 Jan 01; 65(1):264-76. PubMed ID: 15665303
    [Abstract] [Full Text] [Related]

  • 19. Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.
    Aggarwal BB, Bhardwaj U, Takada Y.
    Vitam Horm; 2004 Jan 01; 67():453-83. PubMed ID: 15110190
    [Abstract] [Full Text] [Related]

  • 20. TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2.
    Munshi A, Pappas G, Honda T, McDonnell TJ, Younes A, Li Y, Meyn RE.
    Oncogene; 2001 Jun 28; 20(29):3757-65. PubMed ID: 11439339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.